These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 25174930)

  • 21. Antiretroviral nanoparticles: an extended drug delivery modality.
    Destache CJ; Goede M; Belgum T
    Ther Deliv; 2010 Sep; 1(3):383-6. PubMed ID: 22816141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Strategies for Alzheimer's and Parkinson's Diseases by Means of Drug Delivery Systems.
    Cunha S; Amaral MH; Lobo JM; Silva AC
    Curr Med Chem; 2016; 23(31):3618-3631. PubMed ID: 27554805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioimaging predictors of rilpivirine biodistribution and antiretroviral activities.
    Ottemann BM; Helmink AJ; Zhang W; Mukadam I; Woldstad C; Hilaire JR; Liu Y; McMillan JM; Edagwa BJ; Mosley RL; Garrison JC; Kevadiya BD; Gendelman HE
    Biomaterials; 2018 Dec; 185():174-193. PubMed ID: 30245386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotechnology: a magic bullet for HIV AIDS treatment.
    Kumar L; Verma S; Prasad DN; Bhardwaj A; Vaidya B; Jain AK
    Artif Cells Nanomed Biotechnol; 2015 Apr; 43(2):71-86. PubMed ID: 24564348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice.
    Puligujja P; Araínga M; Dash P; Palandri D; Mosley RL; Gorantla S; Poluektova L; McMillan J; Gendelman HE
    Antiviral Res; 2015 Aug; 120():85-8. PubMed ID: 26026666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanotechnological carriers for cancer chemotherapy: the state of the art.
    Estanqueiro M; Amaral MH; Conceição J; Sousa Lobo JM
    Colloids Surf B Biointerfaces; 2015 Feb; 126():631-48. PubMed ID: 25591851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.
    Gao Y; Kraft JC; Yu D; Ho RJY
    Eur J Pharm Biopharm; 2019 May; 138():75-91. PubMed ID: 29678735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
    Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
    Viruses; 2020 May; 12(5):. PubMed ID: 32443728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment.
    Relaño-Rodríguez I; Juárez-Sánchez R; Pavicic C; Muñoz E; Muñoz-Fernández MÁ
    J Nanobiotechnology; 2019 May; 17(1):69. PubMed ID: 31113488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comprehensive Review on Role of Nanoparticles in Therapeutic Delivery of Medicine.
    Rathor S; Bhatt DC; Aamir S; Singh SK; Kumar V
    Pharm Nanotechnol; 2017; 5(4):263-275. PubMed ID: 29141578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.
    Vyas TK; Shah L; Amiji MM
    Expert Opin Drug Deliv; 2006 Sep; 3(5):613-28. PubMed ID: 16948557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.
    Roy U; Ding H; Pilakka-Kanthikeel S; Raymond AD; Atluri V; Yndart A; Kaftanovskaya EM; Batrakova E; Agudelo M; Nair M
    Int J Nanomedicine; 2015; 10():5819-35. PubMed ID: 26425084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry].
    Szebeni J
    Neuropsychopharmacol Hung; 2011 Mar; 13(1):15-24. PubMed ID: 21451188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
    Jain V; Jain S; Mahajan SC
    Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.
    Sharma P; Garg S
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):491-502. PubMed ID: 19931328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection.
    Désormeaux A; Bergeron MG
    J Drug Target; 1998; 6(1):1-15. PubMed ID: 9769017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
    Kanmogne GD; Singh S; Roy U; Liu X; McMillan J; Gorantla S; Balkundi S; Smith N; Alnouti Y; Gautam N; Zhou Y; Poluektova L; Kabanov A; Bronich T; Gendelman HE
    Int J Nanomedicine; 2012; 7():2373-88. PubMed ID: 22661891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies.
    Haeri A; Osouli M; Bayat F; Alavi S; Dadashzadeh S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):1-14. PubMed ID: 29186990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What nanomedicine in the clinic right now really forms nanoparticles?
    Svenson S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(2):125-35. PubMed ID: 24415653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.